We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · November 02, 2022

Risk of Acute Liver Injury Following the mRNA (BNT162b2) and Inactivated (CoronaVac) COVID-19 Vaccines

Journal of Hepatology


Additional Info

Disclosure statements are available on the authors' profiles:

Journal of Hepatology
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
J. Hepatol. 2022 Nov 01;77(5)1339-1348, CKH Wong, LY Mak, ICH Au, FTT Lai, X Li, EYF Wan, CSL Chui, EWY Chan, WY Cheng, FWT Cheng, MF Yuen, ICK Wong

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading